2003-11-12
Short SGA children: etiological aspects, metabolic consequences and effects of GH treatment
Publication
Publication
SGA kinderen met een te kleine lengte: etiologische aspecten, metabole consequenties en effecten van GH behandeling
Abstract
In 1997 the author of the present thesis started studies relating to short children born small for gestational age (SGA).The present chapter describes definitions of SGA, prevalence and etiology of SGA, factors involving fetal growth and features of short children born SGA.Also an overview of the literature is presented concerning the effects of growth hormone (GH) treatment on growth in these children. Finally, the aims of the study, study design and in- and exclusion criteria of this Dutch multicenter trial are described.
| Additional Metadata | |
|---|---|
| , , , , | |
| S.L.S. Drop (Stenvert) | |
| Erasmus University Rotterdam | |
| The studies described in this thesis were financially supported by Novo Nordisk Farma B.V.The Netherlands and by a grant from the Ter Meulen Fonds (Royal Netherlands Academy of Arts and Sciences). Printing of this thesis was financially supported by Novo Nordisk Farma B.V. The Netherlands and Novo Nordisk A/S, Denmark. | |
| hdl.handle.net/1765/51255 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Arends, N. (2003, November 12). Short SGA children: etiological aspects, metabolic consequences and effects of GH treatment. Retrieved from http://hdl.handle.net/1765/51255 |
|
